EDITORS NOTE: MAY 26 2020
Pure Sars-Cov-2 Available / Vaccines at
High Dose Toxic and May Not be Effective
The CDC has a pure culture available. The CDC can grow enough pure SARS-COV-2 to inoculate millions. This avoids the other pathogens that might be in a COVID sample acquired from the stool or spit. This makes possible is a pure COVID without any other pathogens or parasites.
SAFETY OF RNA VACCINES vs COLON COVID
Please read the side effects of RNA vaccine company attached below. Compare effects of messenger RNA VIRAL INJECTION to colon COVID which rarely has complications except for loose stool or occasional diarrhea. The therapeutic index of colon COVID inoculation is likely far more than the IM RNA vaccine. An RNA vaccine was tried in Phase 1 on 12 volunteers. Three of four given high dose RNA developed side effects requiring medical attention. Eight people who got 25 to 100 mcg of Moderna seemed to do OK. But one of four getting 100 MCG dose had local redness. But once you get to 250 mcg on the second dose of RNA vaccine three subjects people had systemic GRADE 3 ADVERSE EVENTS. Someone can have a billion COVID in their colon and never require medical attention. The goal of inoculation is to start a real not fake infection and develop real immunity.
Someone take 1000 times the normal inoculation dose and have few if any symptoms. Millions of children and young adults with billions of colon COVID and never required hospitalization. If you gave adults 100 times the high dose of RNA vaccine it would be a dangerous 25000 mcg or 100 times the dose that was associated with Grade 3 side effects. Conclusion, The COVID inoculation of the COLON has much fewer side effects than a high dose RNA vaccine.
Someone can have a billion live COVID or 1000 times the inoculation dose without requiring hospitalization. Some people have a stool with 100,000 viruses of COVID per milliliter of stool and have no symptoms except loose stool. So the COVID live virus in the colon is tolerated much better than the RNA vaccine injection of the arm. RNA manufacturers do not claim its vaccine is safe in super high doses. The AMENDED phase two plan of RNA clinical trial eliminated a high dose for safety. High dose COVID in the digestive tract is far better tolerated than high dose RNA injections. RNA vaccines may still have an important role in the treatment of high-risk groups including elderly, healthcare workers, and nursing homes. RNA vaccines are important research and may have many future applications.
The Phase 1 RNA vaccine announcement referred to the level of antibody IgG and IgM in the blood that are equal to level in mice. It is clear that natural infections such as those that occur in colon COVID inoculation produce immunity. But elevated IgG and IgM are not proof of efficacy. IgA is stimulated by digestive COVID and IgA protects epithelium. People need epithelial IgA defense. IgA that binds to COVID virus in the alveoli is suspected as a mechanism to prevent alveolar infection. When mice inhale COVID, it activates the IgA system of mice which protects alveolus. Inhalation produces a rise of IgA and IgG and IgM. The RNA virus phase one study only measured IgG and IgM not IgA.
RNA vaccine company mentions on mice inhalation model to support the efficacy of injection of RNA Vaccine. The injection of RNA may or may not produce IgA of alveoli for the epithelial defense of alveoli. No one guarantees RNA to protect alveolus. RNA company never measured IgA in the phase 1 trial. The RNA manufacturer does not claim proof of efficacy. But we know that those who get real natural COVID infections on endoderm [respiratory tract and colon] get at least temporary immunity. Billions of people have had infections of coronavirus in the colon for thousands of years without severe symptoms. Inoculation with digestive COVID is very likely safe and effective under the right circumstances under a physician’s direction during research studies. If millions of colons already have had COVID without complications, what damage is there if a few more colons receive COVID?